The Clorox Company (CLX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
The Clorox Company stock (CLX) is currently trading at $104.76. The Clorox Company PE ratio is 17.15. The Clorox Company PS ratio (Price-to-Sales) is 1.89. Analyst consensus price target for CLX is $123.47. WallStSmart rates CLX as Underperform.
- CLX PE ratio analysis and historical PE chart
- CLX PS ratio (Price-to-Sales) history and trend
- CLX intrinsic value — DCF, Graham Number, EPV models
- CLX stock price prediction 2025 2026 2027 2028 2029 2030
- CLX fair value vs current price
- CLX insider transactions and insider buying
- Is CLX undervalued or overvalued?
- The Clorox Company financial analysis — revenue, earnings, cash flow
- CLX Piotroski F-Score and Altman Z-Score
- CLX analyst price target and Smart Rating
The Clorox Company
📊 No data available
Try selecting a different time range
CLX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · The Clorox Company (CLX)
CLX trades 203% above its Graham fair value of $41.55, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
The Clorox Company (CLX) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, return on equity, price/sales. Concerns around price/book and revenue growth. Fundamentals are solid but monitor weak areas for improvement.
The Clorox Company (CLX) Key Strengths (4)
Every $100 of shareholder equity generates $99 in profit
84.81% of shares held by major funds and institutions
Large-cap company with substantial market presence
Paying $1.89 for every $1 of annual revenue
Supporting Valuation Data
The Clorox Company (CLX) Areas to Watch (6)
Revenue declining -0.80%, a shrinking business
Earnings declining -16.20%, profits shrinking
Very expensive at 41.4x book value
Paying a premium for growth, expensive relative to earnings expansion
Thin operating margins with cost pressures present
Decent profitability, keeps $11 per $100 revenue
The Clorox Company (CLX) Detailed Analysis Report
Overall Assessment
This company scores 51/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 2.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Return on Equity, Institutional Own., Market Cap. Valuation metrics including Price/Sales (1.89) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 98.70%.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Price/Book. Some valuation metrics including PEG Ratio (2.17), Price/Book (41.40) suggest expensive pricing. Growth concerns include Revenue Growth at -0.80%, EPS Growth at -16.20%, which may limit upside. Profitability pressure is visible in Operating Margin at 14.10%, Profit Margin at 11.20%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 98.70% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at -0.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Return on Equity, Institutional Own.) and negatives (Revenue Growth, EPS Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CLX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CLX's Price-to-Sales ratio of 1.89x sits near its historical average of 2.15x (39th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 46% below its historical high of 3.48x set in Nov 2018, and 51% above its historical low of 1.25x in Feb 2009. Over the past 12 months, the PS ratio has compressed from ~2.3x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for The Clorox Company (CLX) · CONSUMER DEFENSIVE › HOUSEHOLD & PERSONAL PRODUCTS
The Big Picture
The Clorox Company faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 6.8B with 80% decline year-over-year. Profit margins of 11.2% are healthy, with room for further expansion as the business scales.
Key Findings
ROE of 9870.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 269M in free cash flow and 311M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 80% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can The Clorox Company push profit margins above 15% as the business scales?
Dividend sustainability with a current yield of 4.8%. Watch payout ratio and free cash flow coverage.
Sector dynamics: monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive moves, and regulatory changes that could impact The Clorox Company.
Bottom Line
The Clorox Company faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(19 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 8:23:09 AM
About The Clorox Company(CLX)
NYSE
CONSUMER DEFENSIVE
HOUSEHOLD & PERSONAL PRODUCTS
USA
The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.